Please select the option that best describes you:

Do you offer adjuvant therapy for localized medullary carcinoma of the ascending colon that is MSI-H?  

Do you use the same high risk factors as adenocarcinoma when deciding on adjuvant treatment for early stage disease?



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at University Of Wisconsin Department Of Medicine
Thank you, Dr. @Anita Turk. I have a similar situa...
Medical Oncologist at St Louis Cancer Care LLP
I have a patient in her late 80s with one positive...
Sign in or Register to read more